[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 1094 Introduced in House (IH)]
<DOC>
118th CONGRESS
2d Session
H. RES. 1094
Recognizing the significance of Sjogren's as a serious and systemic
autoimmune disease and designating April as ``Sjogren's Awareness
Month''.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
March 19, 2024
Mr. Morelle submitted the following resolution; which was referred to
the Committee on Energy and Commerce
_______________________________________________________________________
RESOLUTION
Recognizing the significance of Sjogren's as a serious and systemic
autoimmune disease and designating April as ``Sjogren's Awareness
Month''.
Whereas up to 4,000,000 adults in the United States are living with Sjogren's;
Whereas Sjogren's is a systemic autoimmune disease that affects the entire
body--
(1) symptoms include extensive dryness throughout the body, including
the eyes and mouth, profound fatigue, and chronic pain;
(2) the average age for diagnosis is currently between the ages of 45
and 55, although Sjogren's can affect all ages; and
(3) the female-to-male ratio for Sjogren's diagnosis is approximately
9:1;
Whereas the cause of Sjogren's is not known, and there is no single test to
diagnose the autoimmune disease;
Whereas Sjogren's is not easily treated and is primarily palliative, with over-
the-counter products used to manage dryness symptoms along with off-
label prescriptions for anti-inflammatory and disease-modifying
therapies;
Whereas individuals living with Sjogren's are often subjected to higher out-of-
pocket costs, in order to afford medications to control inflammation and
dryness, relieve joint, muscle and nerve pain, reduce acid reflux due to
limited saliva production, and treat the devastating complications of
oral and other dryness;
Whereas rheumatologists primarily treat individuals with Sjogren's, a wide
variety of specialists are involved, including dentists, neurologists,
ocular specialists, otolaryngologists, gastroenterologists,
nephrologists, and pulmonologists, among others;
Whereas the physical and psychological impact of Sjogren's can severely affect
an individual's duties at home and in the workplace;
Whereas there is a need to update the nomenclature to classify Sjogren's as a
disease;
Whereas there is a need for more research to understand the pathology that leads
to the autoimmune attack in Sjogren's, including the role of the
interplay of the immune and nervous systems;
Whereas clinical trials are underway to test the efficacy of targeted therapies
that will address the cause of Sjogren's;
Whereas research is underway to identify genes and environmental influences that
may contribute to understanding who is susceptible to Sjogren's; and
Whereas more research is needed to identify new therapies to help individuals
with Sjogren's manage the symptoms and complications as they age: Now,
therefore, be it
Resolved, That the House of Representatives--
(1) recognizes the importance of Sjogren's as a serious
health issue that causes a significant health burden;
(2) encourages the Department of Health and Human Services
and relevant agencies--
(A) to identify new areas of research to improve
the understanding of the causes and identify biomarkers
that will help with patient stratification and
diagnosis, disease management, and development of
targeted therapies for Sjogren's patients;
(B) to better quantify the number of patients
suffering from Sjogren's as many are believed to be
undiagnosed or are misdiagnosed;
(C) to update and disseminate literature on
Sjogren's to public health professionals to increase
awareness for the condition; and
(D) to build awareness among physicians and
communities in underserved areas so that patients are
diagnosed correctly and obtain needed care.
<all>